SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Biopsys Medical Inc – ‘10-Q’ for 9/30/96 – EX-27

As of:  Tuesday, 11/12/96   ·   For:  9/30/96   ·   Accession #:  912057-96-25361   ·   File #:  0-28016

Previous ‘10-Q’:  None   ·   Next:  ‘10-Q’ on 2/12/97 for 12/31/96   ·   Latest:  ‘10-Q’ on 5/5/97 for 3/31/97

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

11/12/96  Biopsys Medical Inc               10-Q        9/30/96    3:25K                                    Merrill Corp/FA

Quarterly Report   —   Form 10-Q
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                      12     47K 
 2: EX-11.1     Statement re: Computation of Earnings Per Share        1      5K 
 3: EX-27       Exhibit 27 FDS                                         2      8K 


EX-27   —   Exhibit 27 FDS

EX-271st Page of 2TOCTopPreviousNextBottomJust 1st
 

[Download Table]
EX-27Last Page of 2TOC1stPreviousNextBottomJust 2nd
<ARTICLE> 5 <LEGEND> THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE UNAUDITED BALANCE SHEET AND STATEMENT OF OPERATIONS CONTAINED IN THE BIOPSYS MEDICAL, INC.'S FORM 10Q FOR THE FIRST QUARTER ENDED SEPTEMBER 30, 1996 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS. </LEGEND> <PERIOD-TYPE> 3-MOS <FISCAL-YEAR-END> JUN-30-1997 <PERIOD-START> JUL-1-1996 <PERIOD-END> SEP-30-1996 <CASH> 8,906,000 <SECURITIES> 6,419,000 <RECEIVABLES> 1,545,000 <ALLOWANCES> (72,000) <INVENTORY> 2,160,000 <CURRENT-ASSETS> 19,214,000 <PP&E> 1,018,000 <DEPRECIATION> 168,000 <TOTAL-ASSETS> 40,529,000 <CURRENT-LIABILITIES> 1,472,000 <BONDS> 0 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 10,000 <OTHER-SE> 39,047,000 <TOTAL-LIABILITY-AND-EQUITY> 40,529,000 <SALES> 2,401,000 <TOTAL-REVENUES> 2,401,000 <CGS> 1,106,000 <TOTAL-COSTS> 1,106,000 <OTHER-EXPENSES> 1,902,000 <LOSS-PROVISION> 18,000 <INTEREST-EXPENSE> 0 <INCOME-PRETAX> (138,000) <INCOME-TAX> 0 <INCOME-CONTINUING> (138,000) <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> (138,000) <EPS-PRIMARY> (.01) <EPS-DILUTED> (.01)

Dates Referenced Herein

Referenced-On Page
This ‘10-Q’ Filing    Date First  Last      Other Filings
11/14/96None on these Dates
Filed on:11/12/96
For Period End:9/30/962
 List all Filings 
Top
Filing Submission 0000912057-96-025361   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., Apr. 23, 3:39:10.1am ET